Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yukari Asamiya
Role of Sclerostin in the Pathogenesis of Chronic Kidney Disease-Mineral Bone Disorder
Renal Replacement Therapy
Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient With Steroid-Resistant Nephrotic Syndrome
Internal Medicine
Internal Medicine
Medicine
Related publications
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
International Journal of Nephrology and Renovascular Disease
Nephrology
Association of Serum Sclerostin With Bone Sclerostin in Chronic Kidney Disease Is Lost in Glucocorticoid Treated Patients
Calcified Tissue International
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Oral and Maxillofacial Manifestations of Chronic Kidney Disease–mineral and Bone Disorder: A Multicenter Retrospective Study
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Nuclear Medicine
Radiology
Oral Surgery
Imaging
Dentistry
Forensic Medicine
Pathology
Surgery
Vascular Calcification in Chronic Kidney Disease: Role of Disordered Mineral Metabolism
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Optimal Management of Bone Mineral Disorders in Chronic Kidney Disease and End Stage Renal Disease
Current Opinion in Nephrology and Hypertension
Internal Medicine
Nephrology
Racial Variations in the Markers of Mineral Bone Disorders in Chronic Kidney Disease Patients in South Africa
Kidney International Reports
Nephrology
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Kidney International Supplements
Nephrology
Role and Mechanism of Action of Sclerostin in Bone
Bone
Endocrinology
Physiology
Histology
Metabolism
Diabetes
Chronic Pain in Hemodialysis Patients: Role of Bone Mineral Metabolism
Alexandria Journal of Medicine
